BR112023005385A2 - Vírus sintéticos - Google Patents
Vírus sintéticosInfo
- Publication number
- BR112023005385A2 BR112023005385A2 BR112023005385A BR112023005385A BR112023005385A2 BR 112023005385 A2 BR112023005385 A2 BR 112023005385A2 BR 112023005385 A BR112023005385 A BR 112023005385A BR 112023005385 A BR112023005385 A BR 112023005385A BR 112023005385 A2 BR112023005385 A2 BR 112023005385A2
- Authority
- BR
- Brazil
- Prior art keywords
- viruses
- synthetic
- modified
- methods
- synthetic viruses
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 8
- 238000000034 method Methods 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10141—Use of virus, viral particle or viral elements as a vector
- C12N2795/10143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
VÍRUS SINTÉTICOS. A presente invenção refere-se a vírus modificados que são sintéticos, composições compreendendo tais vírus, ensaios de infectividade de vírus e métodos de seleção de vírus sintéticos modificados. A invenção refere-se também a métodos de modificação de vírus para produzir vírus sintéticos modificados compreendendo ácido nucleico heterólogo (DNA ou RNA).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2015255.9A GB202015255D0 (en) | 2020-09-26 | 2020-09-26 | Synthetic viruses |
| PCT/EP2021/076360 WO2022063986A2 (en) | 2020-09-26 | 2021-09-24 | Synthetic viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023005385A2 true BR112023005385A2 (pt) | 2023-04-25 |
Family
ID=73197286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023005385A BR112023005385A2 (pt) | 2020-09-26 | 2021-09-24 | Vírus sintéticos |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP4217473A2 (pt) |
| JP (1) | JP2023542410A (pt) |
| KR (1) | KR20230075482A (pt) |
| CN (1) | CN116888261A (pt) |
| AU (1) | AU2021348243A1 (pt) |
| BR (1) | BR112023005385A2 (pt) |
| CA (1) | CA3171502A1 (pt) |
| FR (1) | FR3114600A1 (pt) |
| GB (1) | GB202015255D0 (pt) |
| IL (1) | IL301497A (pt) |
| WO (1) | WO2022063986A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4233546A3 (en) | 2015-05-06 | 2023-09-27 | SNIPR Technologies Limited | Altering microbial populations & modifying microbiota |
| CN117737001A (zh) * | 2022-12-27 | 2024-03-22 | 菲吉乐科(南京)生物科技有限公司 | 一种防治犬细菌性腹泻的大肠杆菌噬菌体及其应用 |
| CN118048315A (zh) * | 2023-09-01 | 2024-05-17 | 青岛农业大学 | 一株沙门氏菌噬菌体及其应用和沙门氏菌噬菌体联合抗菌药的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8505027D0 (sv) * | 1985-10-24 | 1985-10-24 | Kabigen Ab | A lytic virulent phage, a hostcell containing same and a process for protein production |
| US10144778B2 (en) | 2014-03-12 | 2018-12-04 | Yeda Research And Development Co. Ltd | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS |
| EP3810163A1 (en) * | 2018-06-19 | 2021-04-28 | GlaxoSmithKline Biologicals SA | Immunogenic composition |
| US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
-
2020
- 2020-09-26 GB GBGB2015255.9A patent/GB202015255D0/en not_active Ceased
-
2021
- 2021-09-24 WO PCT/EP2021/076360 patent/WO2022063986A2/en active Application Filing
- 2021-09-24 AU AU2021348243A patent/AU2021348243A1/en active Pending
- 2021-09-24 KR KR1020237013608A patent/KR20230075482A/ko unknown
- 2021-09-24 BR BR112023005385A patent/BR112023005385A2/pt unknown
- 2021-09-24 CN CN202180079418.4A patent/CN116888261A/zh active Pending
- 2021-09-24 JP JP2023518933A patent/JP2023542410A/ja active Pending
- 2021-09-24 EP EP21785795.2A patent/EP4217473A2/en active Pending
- 2021-09-24 IL IL301497A patent/IL301497A/en unknown
- 2021-09-24 CA CA3171502A patent/CA3171502A1/en active Pending
- 2021-09-26 FR FR2110112A patent/FR3114600A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB202015255D0 (en) | 2020-11-11 |
| WO2022063986A2 (en) | 2022-03-31 |
| JP2023542410A (ja) | 2023-10-06 |
| CN116888261A (zh) | 2023-10-13 |
| IL301497A (en) | 2023-05-01 |
| EP4217473A2 (en) | 2023-08-02 |
| FR3114600A1 (fr) | 2022-04-01 |
| WO2022063986A3 (en) | 2022-06-16 |
| AU2021348243A1 (en) | 2023-06-01 |
| CA3171502A1 (en) | 2022-03-31 |
| KR20230075482A (ko) | 2023-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023005385A2 (pt) | Vírus sintéticos | |
| WO2018136396A3 (en) | Crisprs | |
| EA201991440A1 (ru) | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 | |
| EA201890032A1 (ru) | Термостабильные нуклеазы cas9 | |
| EA201791343A1 (ru) | Композиции и способы для конструирования вирусного генома in vitro | |
| WO2007047778A3 (en) | Compositions for use in identification of influenza viruses | |
| CL2021000028A1 (es) | Anticuerpo multiespecifico (divisional de solicitud 937-2020). | |
| ATE460473T1 (de) | Immortalisierte entezelllinien zur viruserzeugung | |
| ATE550441T1 (de) | Verfahren, zusammensetzungen und kits zur isothermischen amplifikation von nukleinsäuren | |
| WO2007002008A3 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells | |
| BR112016019267A2 (pt) | métodos e composições para perfil de dna | |
| EA201201025A1 (ru) | Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них | |
| AR115041A1 (es) | Meganucleasas optimizadas diseñadas mediante ingeniería que poseen especificidad para una secuencia de reconocimiento en el genoma del virus de la hepatitis b | |
| AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
| BR112022026311A2 (pt) | Nucleases crispr-cas de ocorrência não natural para edição de genoma | |
| AR119869A1 (es) | Proteína vp1 modificada aislada de la cápside del virus adeno-asociado de serotipo 5 (aav5), cápside y vector basado en la misma | |
| BRPI0604502A (pt) | controles de ensino de metilação de gene | |
| Motard et al. | A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease | |
| AR067439A1 (es) | Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4 | |
| EP4219771A3 (en) | Compositions and methods for multiplex detection of viral pathogens in samples | |
| BR112016017333A2 (pt) | vacinas contra o reovírus aviário | |
| BR112015017788A2 (pt) | Construto de dna, método para produzir uma planta, método de detecção da presença de uma molécula de ácido nucleico, par de iniciadores de polinucleotídio, evento de milho, método de detecção da presença do dna e kit para detectar ácidos nucleicos | |
| Tseng et al. | A complete molecular diagnostic procedure for applications in surveillance and subtyping of avian influenza virus | |
| BR112018072729A2 (pt) | sistema genético reverso do vírus da zica | |
| MX2020004475A (es) | Composiciones y metodos antivirales de amplio espectro. |